Intensity Therapeutics (INTS) Accumulated Expenses (2022 - 2026)
Intensity Therapeutics' Accumulated Expenses came in at $1.2 million for Q2 2026, up 27.8% from $941,000 a year earlier but down 23.6% from the prior quarter.
Powered by 
Analysis
Intensity Therapeutics (INTS) Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Intensity Therapeutics' Accumulated Expenses was $1.53 million, up 201.6% from FY2024.
- Accumulated Expenses carries a three-year compound annual growth rate of -3.9% (FY2022 to FY2025).
- Going back by year, Accumulated Expenses was $508,000 in FY2024 (-43.0%), $891,000 in FY2023 (-48.3%) and $1.72 million in FY2022.
- The five-year range for quarterly Accumulated Expenses is $355,006 (Q3 2023) to $1.75 million (Q3 2024).
- Year-over-year, Accumulated Expenses has increased for three consecutive quarters, with growth averaging 65.1% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in Q3 2024 (growth of 392.7%), and the weakest in Q3 2025 (a decline of 67.9%).
- Business Quant data shows INTS's Accumulated Expenses at $1.57 million (Q1 2026), $1.53 million (Q4 2025) and $561,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn |
| 10 | Intensity Therapeutics | 9.50 Mn | -29.26 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.57 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 561,000.00 |
| Jun 30, 2025 | 941,000.00 |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 508,000.00 |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 891,000.00 |
| Sep 30, 2023 | 355,006.00 |
| Jun 30, 2023 | 1.48 Mn |
| Mar 31, 2023 | 891,000.00 |
| Dec 31, 2022 | 1.72 Mn |
API Access
Intensity Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=INTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "INTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=INTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();